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a b s t r a c t
JC virus (JCV) lytically infects the oligodendrocytes in the central nervous system in a subset of
immunocompromized patients and causes the demyelinating disease, progressive multifocal leukoence-
phalopathy. JCV replicates and assembles into infectious virions in the nucleus. However, understanding
the molecular mechanisms of its virion biogenesis remains elusive. In this report, we have attempted to
shed more light on this process by investigating molecular interactions between large T antigen (LT-Ag),
Hsp70 and minor capsid proteins, VP2/VP3. We demonstrated that Hsp70 interacts with VP2/VP3 and
LT-Ag; and accumulates heavily in the nucleus of the infected cells. We also showed that VP2/VP3
associates with LT-Ag through their DNA binding domains resulting in enhancement in LT-Ag DNA
binding to Ori and induction in viral DNA replication. Altogether, our results suggest that VP2/VP3 and
Hsp70 actively participate in JCV DNA replication and may play critical roles in coupling of viral DNA
replication to virion encapsidation.
& 2013 Elsevier Inc. All rights reserved.
Introduction
JC virus (JCV) is a small, double-stranded human DNA virus that
causes a fatal demyelinating disease of the human brain, known as
progressive multifocal leukoencephalopathy (PML), in a subset of
immunocompromized individuals by speciﬁcally and lytically
infecting oligodendrocytes – the myelin producing cells of the
central nervous system (CNS).
Like many other DNA viruses, JCV replicates and assembles into
infectious virions in the nucleus. Upon translation, JCV capsid
proteins enter the nucleus to build the different layers of the
virions. During this process, the viral genome and histones form
the inner core and two capsid proteins, VP2 and VP3 tightly wrap
around the viral genome. Maturation of the virions is thought to
be ﬁnalized by a regulated assembly process of the third
capsid protein, VP1, which forms the outer layer of the infectious
particles. However, the mechanistic details of virion assembly of
JCV remain elusive. One of the key players in this assembly process
is thought to be the host chaperone system, including the heat
shock protein 70 (Hsp70). Heat shock proteins are rapidly induced
by viral infection (Beere and Green, 2001) and are frequently
recruited by numerous viruses (Mayer, 2005) to facilitate the
various stages of the viral life cycle including genome replication
(Chromy et al., 2003), transcription (Devireddy et al., 2000), cell
entry (Guerrero et al., 2002) and virion assembly (Napuli et al.,
2003). Without the regulatory activities of heat shock proteins,
viruses cannot complete their replication cycle (Mayer, 2005).
The primary function of the heat shock proteins is to assist the
proper folding of newly synthesized proteins, to prevent their
aggregation and to direct damaged proteins to the ubiquitin-
proteasome system for degradation. Hsp70 consists of two distinct
functional domains: (i) the C-terminal substrate binding domain,
which mediates the target binding and refolding of the substrates
and (ii) the N-terminal ATP hydrolysis (ATPase) domain, which
facilitates the release of the client protein upon ATP hydrolysis
(Vogel et al., 2006). The heat shock family of proteins requires
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a diverse group of co-chaperones for their function, including
(i) J-domain co-chaperones (Young et al., 2004), (ii) the nucleotide
exchange factor co-chaperones which catalyze the release of ADP
that is required for the completion of Hsp70 ATPase cycle
(e.g. Bag1, Hsp110 and HspBP1) and (iii) tetratricopeptide repeat
(TPR)-domain co-chaperones (Hop, Chip) which are required for
the combinatorial assembly of Hsp70 and Hsp90 complexes to
mediate the stability of the Hsp90 client proteins (Mayer, 2005).
The critical importance of Hsp70 family in the replication of
many viruses has been previously established (Chromy et al.,
2003; Devireddy et al., 2000; Georgopoulos, 1977; Georgopoulos
et al., 1972; Guerrero et al., 2002; Liberek et al., 1988; Liu et al.,
1998; Mayer, 2005; Napuli et al., 2003), including SV40, BKV, and
PyV (Chromy et al., 2003). Besides many other functions of Hsp70,
there are reports describing the involvement of Hsp70 system in
virion morphogenesis as well, where the interaction of Hsp70 with
capsid proteins (VP1, VP2 and VP3) of mouse polyomavirus (PyV)
was demonstrated (Chromy et al., 2003). Puriﬁed VP1 and VP3 can
assemble into virion-like structures in the presence of prokaryotic
Hsp70 (DnaK, DnaJ and GrpE) chaperones in an ATP-dependent
manner. Such an assembly was also demonstrated using a func-
tional mammalian Hsp70 when the J-domain of SV40 LT-Ag was
used as co-chaperone for Hsp70 (Chromy et al., 2003).
The early open reading frame of JCV, BK virus (BKV) and Simian
virus-40 (SV40) encodes primarily two regulatory proteins, large T
antigen (LT-Ag) and small t antigen (Sm t-Ag), which are produced by
the alternative splicing of a singly precursor early mRNA (An et al.,
2012; White et al., 1992). The production of the additional small
regulatory proteins originating from the viral early transcripts has
also been reported for several polyomaviruses, including a 17 kD T
protein for SV40 (Zerrahn et al., 1993), a tiny T protein for PyV (Riley
et al., 1997), a 17–20 kD T protein for BKV (Abend et al., 2009) and
three T' proteins for JCV (Bollag et al., 2000; Prins and Frisque, 2001).
The precise function of these small proteins is not known. However,
one of the unifying structural features of all the polyomavirus early
proteins is to have common sequences at their respective N-terminal
region, which contains a co-chaperone J-domain regardless of their
size. The J-domain shows signiﬁcant sequence homology to the DnaJ
family of chaperons, which are conserved from bacteria to human.
This domain strongly interacts with the C-terminal region of host
Hsp70 in a ATP-dependent manner (Sullivan et al., 2001; Sullivan and
Pipas, 2002) and plays important regulatory roles in determining the
substrate speciﬁcity of the Hsp70 family of proteins during viral DNA
replication and cell transformation (Nevins, 1998; Zalvide et al., 1998).
Moreover, this domain also contains a conserved HPD loop, which is
essential for its co-chaperone activity (Kelley, 1999). Biochemical
studies have shown that the J-domain of T antigen functions as co-
chaperone in multiple assays, which include stimulation of the
binding activity of LT-Ag to Hsp70 (Campbell et al., 1997; Sawai and
Butel, 1989; Sullivan et al., 2001), promotion of the release of bound
substrate (Srinivasan et al., 1997) and ATPase activity of bovine Hsp70
(Srinivasan et al., 1997). Furthermore, mutational analysis of the J-
domain of SV40 LT-Ag (L19F, P28S) revealed that this domain may
also be involved in virion assembly (Spence and Pipas, 1994a; Spence
and Pipas, 1994b).
In this report, we investigated molecular interactions taking place
between JCV LT-Ag, Hsp70 and the JCV minor capsid proteins, VP2 and
VP3. We also characterized a functional consequence of a speciﬁc
interaction between LT-Ag and capsid proteins (VP2/VP3) using
deletion mutants of VP2/VP3 by replication assays. Our data demon-
strated that Hsp70 interacts with capsid proteins, VP2/VP3, and LT-Ag;
and accumulates heavily in the nucleus of the infected cells, suggest-
ing a role for them in virion biogenesis. Mapping studies revealed a
strong interaction between the capsid proteins (VP2/VP3) and LT-Ag,
mediated by the DNA binding domain of each capsid protein (aa
281–344) (Gasparovic et al., 2006; Huang et al., 2003). This
interaction resulted in a marked enhancement in the DNA binding
activity of LT-Ag to Ori. Our data also show that the DNA binding
domain of each capsid protein is sufﬁcient for the observed enhance-
ment, indicating a possible cooperation between this region and LT-
Ag in JCV virion biogenesis. Finally, the functional consequence of the
interaction between capsid proteins and LT-Ag was also tested by
viral DNA replication assays using speciﬁc deletion mutants of the
capsid proteins. Results revealed that the efﬁciency of the LT-Ag-
mediated viral DNA replication is signiﬁcantly elevated in the
presence of VP2 and the DNA binding domain of VP2/VP3 is sufﬁcient
for this enhancement, which conﬁrms the functional interaction
between capsid proteins and LT-Ag. Collectively, these ﬁndings
suggest that JCV minor capsid proteins and the host Hsp70, actively
participate in LT-Ag-mediated viral DNA replication and may play
essential roles on coupling of the viral DNA replication to the
encapsidation process.
Results
Bacterial heat shock protein, DnaK, co-puriﬁes with JCV capsid
protein, VP3
The polyomaviridae family of viruses is small, non-enveloped,
icosahedral DNA viruses including JCV, BKV, SV40 and PyV. Both
the viral capsid proteins and viral genome assemble into the
highly organized infectious particles in the nucleus, but the
mechanism of the assembly process is largely unknown. X-ray
crystallography studies on PyV (Liddington et al., 1991) and
monkey polyomavirus, SV40 (Grifﬁth et al., 1992) revealed that
the outer shell of each virion is composed of 72 pentamers of the
major capsid protein, VP1, which is arranged in T¼7 icosahedral
lattice and inner structures are made up of two minor capsid
proteins, VP2 and VP3 and viral genome. There are numerous
reports in the literature, indicating that the host heat shock
protein, Hsp70, plays a critical role in this highly regulated viral
assembly process during the maturation steps of these viruses.
To investigate the mechanisms of JCV virion biogenesis, JCV
capsid proteins, including VP3, was fused to GST, expressed in
bacteria, afﬁnity puriﬁed and analyzed by SDS-PAGE followed by
Coomassie blue staining. As shown in Fig. 1A, full-length VP3 (GST-
VP3) migrated around 41 kDa (lane 3). Interestingly, we also
observed an additional protein band migrating closer to 70 kDa,
the identity of which was determined to be bacterial heat shock
protein, DnaK, by proteomic sequencing studies. These ﬁndings
demonstrate that DnaK strongly interacts with JCV VP3 and
therefore co-puriﬁes with it but not with GST alone indicating a
speciﬁc interaction between DnaK and VP3.
Host Hsp70 interacts with capsid protein, VP3
We, next, investigated whether Hsp70 also interacts with the
viral capsid protein, VP3, by a powerful biochemical technique,
GST-pull down assay. To assess this, bacterially expressed GST or
GST-VP3 was immobilized on GSH-Sepharose 4B beads and
incubated with whole-cell extracts prepared from U-87MG cells
as described in Materials and methods and in the ﬁgure legend.
Proteins bound to GST or GST-VP3 were analyzed by western
blotting using an anti-Hsp70 antibody. As shown in Fig. 1B, Hsp70
strongly interacts with the viral capsid protein, VP3 (lane 3).
A similar interaction between Hsp70 and GST alone was not
detectable (lane 2), indicating the speciﬁcity of association
between Hsp70 and VP3 and also supporting our ﬁndings from
GST-VP3 bacterial expression studies, where we observed the
co-puriﬁcation of bacterial heat shock protein, DnaK with VP3
(Fig. 1A).
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Hsp70 is induced by JCV infection and accumulates in the nucleus of
the infected cells
JCV encodes a limited number of regulatory proteins and thus
the success of virus proliferation depends on recruitment of host
cellular components and chaperons for its own replication and
virion assembly. Hsp70 chaperons are the central components of
the cellular chaperon network, which are frequently recruited by
viruses. Hsp70 chaperons display a cytoplasmic/nuclear distribu-
tion pattern in cells under unstressed conditions. We next
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Fig. 1. Interaction of JCV VP3 with heat shock protein, Hsp70. (A) SDS-PAGE analysis of bacterially expressed GST and JCV VP3 fused to GST (GST-VP3). Both GST alone and
VP3 cloned into the pGEX1λt vector were expressed in Escherichia coli, afﬁnity puriﬁed and analyzed on a SDS-10% PAGE followed by Coomassie blue staining. The positions
of bacterial heat shock protein, DnaK, GST and GST-VP3 are indicated on the gel by arrows. (B) VP3 interacts with human Hsp70 in GST pull-down assays. Whole-cell extracts
(0.3 mg) prepared from U-87MG cells were incubated with either GST alone (lane 2) or GST-VP3 (lane 3) and immobilized on GSH-Sepharose 4B afﬁnity resin. After extensive
washing, proteins interacting with GST or GST-VP3 were analyzed by western blotting using anti-Hsp70 antibody (W2) for detection of Hsp70 as described in Materials and
methods. In lane 1, 20 mg aliquot of whole cell extract from U-87MG was loaded as positive control. (C) A graphical representation of Hsp70 protein with its subdomains.
(D) Immunocytochemical analysis of Hsp70 in infected SVG-A cells. The cells were transfected with JCV Mad-1 WT and at day 5 posttranfection/infection, ﬁxed with cold
acetone and blocked with 5% BSA (prepared in PBST) for 2 h. Cells were then incubated with a combination of α-Agno (rabbit polyclonal, 1:200 dilution) (Del Valle et al.,
2002) and anti-Hsp70 antibody (W2) (mouse monoclonal, 1:100 dilution) overnight. After washing with PBST three times with (10 min intervals), cells were incubated with
the combination of FITC-conjugated anti-rabbit goat and Rhodamine-conjugated anti-mouse goat secondary antibodies for 45 min. Cells were ﬁnally washed with PBST three
times with 10 min intervals, mounted with mounting media and examined under a ﬂuorescence microscope as described under Materials and methods.
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examined the cellular distribution of Hsp70 during the viral
replication cycle by immunocytochemistry. JCV Mad-1 WT strain
was transfected/infected into SVG-A cells and, at 5th day post-
tranfection/infection, cells were processed for immunocytochem-
istry using anti-Agno (rabbit polyclonal) antibody (Del Valle et al.,
2002) and anti-Hsp70 antibody (W2) (mouse monoclonal); and
examined under a ﬂuorescence microscope as described in Mate-
rials and methods. As previously described (Saribas et al., 2012),
viral regulatory agnoprotein, used as a positive control in this viral
infection experiment, mostly accumulates around the perinuclear
region of the infected cells with small amounts localized to the
nucleus (Saribas et al., 2012). Hsp70, on the other hand, exhibited
an elevated level of expression in the nucleus of the infected cells
compared to that of the cytoplasmic detection, demonstrating that
Hsp70 is induced by JCV infection and accumulates in the nucleus
at relatively high levels (Fig. 1D), which is consistent with the
previous ﬁndings with SV40 infection cases (Li et al., 2009).
JCV LT-Ag interacts with Hsp70 in vitro and in vivo
LT-Ag, a major regulatory protein of JCV, is involved in viral
DNA replication (Lynch and Frisque, 1990, 1991; Lynch et al., 1994;
Tavis and Frisque, 1991), viral gene transcription (Khalili et al.,
1987; Lashgari et al., 1989; Safak et al., 2001) and cell transforma-
tion (Gordon et al., 1998; Krynska et al., 1997, 1999; Tretiakova
et al., 1999); and produced by the viral early coding region.
It shows signiﬁcant sequence homology to the LT-Ag proteins
from SV40 and BKV, with the greatest divergence occurring within
the carboxy-terminal region (Fanning and Knippers, 1992; Frisque
et al., 1984). The JCV early coding region also encodes several small
regulatory proteins by an alternative splicing of the early precursor
RNA, including small t-Antigen (Sm t-Ag) (Frisque et al., 1984) and
T'proteins (T'135, T'136 and T'165) (Bollag et al., 2006, 2000; Frisque
et al., 2003). Similarly, small regulatory proteins were also
encoded by the early coding regions of the SV40, BKV and PyV,
including 17kT protein (Zerrahn et al., 1993), a truncated T (Abend
et al., 2009) and tiny T (Riley et al., 1997).
Several functions of the LT-Ag are regulated in part by discrete
functional domains of the protein, most of which are located
within the amino-terminal portion of the protein (Fig. 2A). For
example, three independently acting transforming functions that
involve adenovirus E1A conserved region 1 (Cr1) motif (E/DXXLXE/
DLXX/I), a Cr2 motif which contains a binding domain (LXCXE) for
the pRB family of proteins and a J domain motif (HPDKGG) (Kelley
and Landry, 1994) which is found in the DnaJ family of molecular
chaperones that interacts with the DnaK family of proteins (Kelley
and Landry, 1994). Interaction of J domain of SV40 LT-Ag with the
host chaperone, Hsp70, was also demonstrated (Zalvide et al.,
1998).
One of the unifying structural features of all the JCV early
proteins is the presence of the commonly shared motifs located
within their amino-terminus, including Cr1 and J-domain motifs
(Fig. 2A), indicating that the common regions of these proteins are
involved in similar functions including binding to the host heat
shock protein, Hsp70. This was investigated by a GST pull-down
assay to demonstrate an interaction between JCV LT-Ag and Hsp70.
GST or GST-LT-Ag immobilized on GSH-Sepharose 4B beads was
incubated with whole-cell extracts prepared from U-87MG cells as
described in Materials and methods. After extensive washing of
the beads with binding buffer, the proteins bound to GST or GST-
LT-Ag were analyzed by western blotting using an anti-Hsp70
antibody. As shown in Fig. 2B, Hsp70 was visibly detected on the
blot with an Hsp70 antibody when GST-LT-Ag is incubated with
extracts (lane 3) but not with the beads that contained GST alone
(Fig. 2B, lane 2). These results indicate a speciﬁc association of
Hsp70 with LT-Ag. In parallel, to analyze the contribution of
42HPD44 motif of LT-Ag to the interaction between LT-Ag and
Hsp70, this motif was mutated to 42AAA44 and GST-pulldown
assays were repeated as described for WT LT-Ag. Results from
these assays demonstrated that the strength of the interaction
between LT-Ag and Hsp70 signiﬁcantly reduced (4 50%) compare
to that of WT (compare lane 4 with 3, Fig. 2B), indicating the
importance of HPD motif in interaction between LT-Ag and Hsp70.
Fig. 2C demonstrates the analysis of GST, GST-LT-Ag and GST-LT-Ag
HPD to AAA mutant proteins by SDS-PAGE followed by coomassie
blue staining.
In parallel, in vivo interaction of Hsp70 with LT-Ag was also
investigated by a coimmunoprecipitation assay using whole cell
extracts prepared from HJC-5b cells, which constitutively express
both JCV LT-Ag and Hsp70 as described under Fig. 2D legend. This
in vivo assay clearly demonstrated that Hsp70 coprecipitates with
LT-Ag when a speciﬁc anti-LT-Ag antibody is used in immunopre-
cipitation assay (Fig. 2D, lane 3) but not with a nonspeciﬁc NMS
(lane 2). These ﬁndings also validate our protein–protein interac-
tion studies by GST pulldown assays shown in Fig. 2B.
VP2 and VP3 associate with LT-Ag
The minor capsid proteins are nuclear proteins with their own
nuclear localization signals (Shishido-Hara et al., 2000), similar to
those of BKV (Shishido-Hara et al., 2000), SV40 (Clever and
Kasamatsu, 1991) and PyV (Chang et al., 1992) VP2/VP3 proteins.
These two proteins are encoded by a single mRNA species with
two ribosomal entry sites and share a 224 amino acid common
sequence region (Fig. 3A). X-ray diffraction data to obtain an
electron-density map of the inside of SV40 virions showed that
these two proteins locate within the inner layers of a virion along
with the viral minichromosome (Grifﬁth et al., 1992). These
structural studies showed that the minor capsid proteins must
come in contact ﬁrst with the viral DNA during the encapsidation
process. In fact, DNA binding studies using JCV (Huang et al., 2003)
and SV40 (Clever et al., 1993) VP2/VP3 proteins demonstrated that
two Lys and Arg-rich cluster regions (Lys319 to Lys324 and Lys332 to
Ser344, for JCV Mad-1) located at the far C-terminus regions of
these proteins (Fig. 3B) play an important role in DNA binding
activity of these proteins. Amino acid comparison studies showed
that the C-terminal region of JCV, BKV and SV40 VP2/VP3 proteins
show high sequence homology. However, there is an 8 amino acid
(V/LSRGGSSQK) differential region, located towards the C-terminal
region of BKV and SV40 VP2/VP3, where they are missing in JCV
VP2/VP3 (Fig. 3B). It is possible that these sequences may play a
differential role in encapsidation process of the viral DNA into the
capsids in these viruses.
Since encapsidation process for JCV takes place in the nucleus
of the infected cells and Hsp70 binds to both LT-Ag and the capsid
proteins, we reasoned that there might be an association between
LT-Ag and JCV capsid proteins as well. This possibility was
investigated by a protein–protein interaction assay. For this, whole
cell extracts prepared from HJC-15b cells, constitutively expressing
JCV LT-Ag (Raj et al., 1995) were incubated with either GST or GST-
VP2 or GST-VP3 immobilized on GSH-Sepharose 4B beads as
described in the legend of Fig. 3. After extensive washing of the
resins with binding buffer, the proteins bound to GST or GST-VP2
or GST-VP3 were analyzed by western blotting using an anti-LT-Ag
antibody. As shown in Fig. 3C, we detected a weak and a strong
signal for LT-Ag on the western blot when whole cell extracts were
incubated GST-VP2 and GST-VP3 respectively (Fig. 3C, lanes 3 and 4),
but no such a signal was detected with resins that adsorbed GST
alone (lane 2). These results demonstrate a speciﬁc interaction
between LT-Ag and VP2 and LT-Ag and VP3.
In order to further investigate whether interaction between JCV
capsid protein, VP2, and LT-Ag also occurs in vivo, we performed
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coimmunoprecipitation assays by using whole cell extracts pre-
pared from HJC 15b cells, which are either untransfected or
transfected with a FLAG-tagged VP2 expression vector and by
using appropriate antibodies as described under respective ﬁgure
legend (Fig. 3D). As shown in Fig. 3D, LT-Ag coprecipitates with
VP2 (lane 3) when a speciﬁc (anti-FLAG antibody) but not non-
speciﬁc NMS (lane 2) antibody is used for immunoprecipitation,
which is consistent with our ﬁndings from in vitro GST-pulldown
assays (Fig. 3C). In parallel, an in vivo interaction between VP2 and
Hsp70 was also examined by coimmunoprecipitation assays as
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Fig. 2. (A) Graphical presentation of JCV early proteins, LT-Ag, Sm t-Ag, and T' proteins (T'-135, T'-136 and T'-165) with several functional domains, including Cr1, J-box and
Cr2 domains (Bollag et al., 2000; Prins and Frisque, 2001; Sariyer et al., 2004; Sullivan et al., 2001; Sullivan and Pipas, 2002). (B) Interaction of Hsp70 with JCV LT-Ag in GST
pull-down assays. Whole-cell extracts (0.3 mg) prepared from U-87MG cells were incubated with either GST alone (2 mg, lane 2) or GST-LT-Ag (2 mg, full length) (lane 3)
or GST-LT-Ag (HPD to AAA) mutant (2 mg) (lane 4), immobilized on the GSH-Sepharose 4B afﬁnity resins. After extensive washing with the washing buffer, proteins
interacting with GST or GST-LT-Ag were analyzed by western blotting using anti-Hsp70 antibody (W2) for detection of Hsp70 as described in Materials and methods using
Odyssey CLX infrared imaging system (Li-COR). In lane 1, 20 mg of whole cell extract from U-87MG was loaded as positive control. (C) Analysis of bacterially expressed and
afﬁnity puriﬁed GST, GST-JCV LT-Ag (full length) and GST-LT-Ag (HPD to AAA) mutant by SDS-10% PAGE followed by Coomassie blue staining. (D) Hsp70 coimmunopre-
cipitates with LT-Ag. Three hundred micrograms of whole-cell extracts prepared from hamster glial cells, HJC-15b (Raj et al., 1995), which constitutively express JCV LT-Ag
and Hsp70, were immunoprecipitated with either normal mouse serum (NMS, 3 mg/lane) (lane 2) or anti-LT-Ag [mouse mAb (PAb416) (lane 3)] antibodies in lysis buffer
containing 50 mM Tris–HCl (pH 7.4), 150 mM NaCl, and 0.5% NP-40. Immunocomplexes were washed with lysis buffer, resolved on a SDS–10% PAGE and analyzed by western
blotting to detect Hsp70 using an anti-Hsp70 (W2) antibody. IP, immunoprecipitation; WB, western blotting. In lane 1, 20 mg protein prepared from HJC-15b cells were loaded
as a positive (þ) control. The positions of immunoglobulin heavy and light chains; and Hsp70 were indicated by arrows.
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Fig. 3. Interaction of JCV LT-Ag with JCV VP2 and VP3 in GST pull-down assays. (A) Graphical representation of JCV Mad-1 VP2/VP3 coding region. Putative DNA binding domain of
both capsid proteins, VP2 and VP3 was indicated. (B) Comparison of the amino acids from the putative DNA binding domains of VP2 for JCV, BKV and SV40 using DNASTAR Lasergene
software (Wisconsin, Madison). (C) JCV LT-Ag interacts with JCV VP2 and VP3. Bacterially expressed GST (lane 2) or GST-VP2 (lane 3) or GST-VP3 (lane 4) was immobilized on
GSH-Sepharose 4B beads and incubated with whole-cell extract prepared from hamster glial cells [HJC-15b, (Raj et al., 1995)] constitutively expressing JCV LT-Ag. Nonbinding proteins
were removed from the beads by extensive washing, and proteins interacting with GST alone or GST-VP2 or GST-VP3 were separated on SDS-10% PAGE and analyzed by western
blotting using an anti-LT-Ag antibody (Ab-2, monoclonal). In lane 1, whole-cell extracts from HJC-15b cells were loaded as a migration control (10 mg/lane). (D) JCV capsid protein,
VP2, coimmunoprecipitates with LT-Ag. Three hundred micrograms of whole-cell extracts prepared from HJC-15b cells transfected with an 3xFLAG-tagged JCV VP2 expression plasmid
[p3xFLAG-CMVTM-7.1-JCV-VP2 (1–344)] were immunoprecipitated with either normal mouse serum (NMS, 3 mg/lane) (lane 2) or anti-FLAG antibody (3 mg/lane) overnight at 4 1C in
lysis buffer containing 0.5% NP-40. Immunocomplexes were washed with lysis buffer, resolved on a SDS–10% PAGE and analyzed by western blotting for detection of LT-Ag using an
anti-LT-Ag (PAb416) (lane 3) antibody. In lane 1, 20 mg protein prepared from HJC-15b cells were loaded as a positive (þ) control. In lane 4, anti-FLAG antibody alone (3 mg/lane) was
subjected to immunoprecipitation as a negative control. The positions of immunoglobulin heavy chain and LT-Ag were indicated by arrows. (E) JCV VP2 interacts with Hsp70 in vivo. In
parallel to the in vivo interaction studies described for LT-Ag and Hsp70 in panel D, a possible protein-protein interaction between JCV VP2 and Hsp70 was also investigated by a
coimmunoprecipitation assay using whole cell extracts (300 mg/lane) prepared from HJC-15b cells untransfected (lanes 3 and 4) or transfected with 3xFLAG-tagged VP2 expression
plasmid (lanes 5 and 6). Coimmunoprecipitation conditions were the same as described for panel D. Ab: Antibody, Transf.: Transfection. In lane 1 and 2, 20 mg protein were separately
loaded from untransfected and transfected cells respectively as controls. In lane 7, anti-FLAG antibody (3 mg/lane) was loaded as a negative control. Note that after protein transfer onto
the membrane, immunoblot was trimmed into two small strips and incubated with anti-Hsp70 (W2 antibody) separately to avoid a competition between IgGs resulting from
antibodies used in immunoprecipitation and Hsp70 for binding to anti-Hsp70 antibody.
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shown in Fig. 3E legend. In agreement with our in vitro GST-
pulldown assays (Fig. 3C), results clearly demonstrated that VP2
also associates with Hsp70 (Fig. 3E, lane 6) in vivo. Findings from
these in vivo studies also strongly suggest a triple protein complex
formation between VP2/VP3, LT-Ag and HSp70 in JCV infected cells
as illustrated in Fig. 9 as a model.
JCV VP2 and VP3 enhance LT-Ag binding to JCV origin of DNA
replication, Ori
Being localized to the nucleus and interacting with LT-Ag (Fig. 3C)
suggested that the JCV structural proteins, VP2 and VP3 may also play
functional roles in JCV replication cycle perhaps by inﬂuencing the
DNA binding activity of LT-Ag to Ori. We explored this possibility
in vitro by employing a band shift assay. For this, we used recombi-
nant proteins (bacterial produced GST, GST-VP2 and GST-VP3; and
baculovirus produced LT-Ag) and a double-stranded nucleotide probe,
which encompasses 5064–5115 nucleotide region of JCV (JCV Mad-1
numbering) which completely overlaps with BS I (binding site I) and
IR (inverted repeat) regions of JCV Ori respectively as shown in Fig. 4A
(Lynch and Frisque, 1990). As expected, LT-Ag formed complexes with
Ori sequences (Fig. 4B, lane 2). The multiple banding patterns that we
observed are most likely due to the interaction of monomeric and
different multimeric forms of LT-Ag with DNA (Borowiec et al., 1990;
Fanning and Knippers, 1992).
Next, we analyzed whether VP2 and VP3 inﬂuence the DNA
binding activity of LT-Ag to its target sequences on the Ori probe.
Interestingly, simultaneous addition of the increasing concentra-
tions of recombinant GST-VP2 (Fig. 4B, lanes 4 and 5) or GST-VP3
(Fig. 4C, lanes 3 and 4) to the reaction mixture signiﬁcantly
enhanced the binding activity of LT-Ag to Ori in a dose-
dependent manner, although neither VP2 (Fig. 4B, lane 6 and F)
nor VP3 (Fig. 4C, lane 5 and G) alone show any binding activity to
Ori, indicating that VP2/VP3 induces LT-Ag binding to DNA while
not binding to DNA itself in the absence of LT-Ag. However,
addition of both capsid proteins, VP2 and VP3 to the reaction
mixture did not alter the banding pattern or mobility of the LT-Ag/
Ori complexes other than enhancing the binding activity of LT-Ag,
suggesting that both capsid proteins interact with LT-Ag off the
DNA and this interaction may result in a conformational change on
LT-Ag which subsequently leads to more efﬁcient binding of LT-Ag
to its target sequences (Fig. 4B and C). Under identical reaction
conditions, the speciﬁcity of the VP2/VP3-mediated enhancement
of LT-Ag binding to DNA was tested using the GST protein in the
binding reactions as well (Fig. 4B, lane 3). In this regard, addition
of GST to the binding reaction did not result in a considerable level
of induction on LT-Ag binding to DNA (Fig. 4B, lane 3 and F)
compared to that observed for GST-VP2 (Fig. 4B, lanes 4 and 5,
and F). This suggests that the binding activity of LT-Ag to its target
sequences is speciﬁcally stimulated by VP2 and VP3 but not GST
(Fig. 4B, compare lane 3 with lane 5). Note that in one of our recent
reports, we also demonstrated that GST alone did not interact with
the same probe at all (Saribas et al., 2012). It is also important to
note here that JCV VP2/VP3 was previously reported to have a DNA
binding activity (Huang et al., 2003) but we did not observe any
DNA activity by these proteins using a speciﬁc JCV Ori sequence as
a probe. This suggests two possibilities: (1) Either these proteins
were not able to bind to DNA under our experimental conditions
or (2) the signal sequences that are required for these proteins
bind to are located at different locations on the JCV minichromo-
some. Additionally, we also investigated the sequence speciﬁc
binding activity of LT-Ag to Ori by including a nonspeciﬁc double
stranded probe in our DNA binding assays. As shown in Fig. 4D,
LT-Ag does not bind to a nonspeciﬁc DNA probe under our DNA
binding assays, conﬁrming the speciﬁc binding activity of LT-Ag to
Ori (Fig. 3D, lane 2). Collectively, these results demonstrate that
the binding activity of JCV LT-Ag to its target sequences within Ori
is speciﬁcally enhanced by the JCV minor capsid proteins, VP2 and
VP3, which is a similar case where we have also recently reported
an enhanced binding activity of LT-Ag to Ori in the presence of JCV
agnoprotein (Saribas et al., 2012).
We further examined the speciﬁcity of interaction of LT-Ag
with the probe by competitive band shift and antibody super-shift
assays. The Ori probe was incubated with LT-Ag protein in the
absence or presence of 50- and 250-fold molar excesses of
unlabeled competitor DNA (Fig. 4E, lanes 3 and 4). It was observed
that, wild-type Ori DNA efﬁciently competes with the labeled
Ori probe for LT-Ag binding (Fig. 4E, lanes 3 and 4). Reaction mixture
was also incubated with either a speciﬁc antibody directed against
LT-Ag or with normal mouse serum (NMS) as indicated. While α-LT-
Ag antibody super-shifted the protein–DNA complexes (compare
lane 5 with 6), the normal mouse serum (NMS) did not have a
noticeable effect on the migration pattern of LT-Ag-Ori complexes. As
a result, both the competitive band shift and the antibody super-shift
assays conﬁrm the speciﬁcity of LT-Ag binding to Ori.
DNA binding domains of VP2 and VP3 are important for their
interaction with LT-Ag.
In the next series of studies, we attempted to identify the
region(s) of VP2/VP3 necessary for the interaction with LT-Ag. For
this purpose, series of amino-terminal and carboxy-terminal
deletion mutants of VP2/VP3 were created as GST fusion proteins
and incubated with whole cells extracts prepared from HJC-15b,
constitutively expressing JCV LT-Ag. The bound complexes were
resolved by western blotting as described in Materials and
methods. As shown in Fig. 5A, three C-terminal deletion mutants
(aa 1–119, aa 1–280 and aa 120–280) which do not contain the
putative DNA binding domain of VP2/VP3 showed no interaction
with LT-Ag (Fig. 5A, lanes 2–4). However, two N-terminal deletion
mutants, which encompasses the previously designated DNA
binding domain of JCV VP2/VP3 (aa 120–344 and aa 281–344)
exhibited a strong binding activity toward LT-Ag (Fig. 5A, lanes
5 and 6). Even the DNA binding domain of both capsid proteins
(aa 281–344) is sufﬁcient for this interaction, indicating that VP2/
VP3 interacts with LT-Ag through their short C-terminal DNA
binding domains. These results along with those from Fig. 3C are
summarized in Fig. 5C. Bacterially produced GST-VP2 and the
deletion mutants of VP2 fused to GST or GST alone were analyzed
by SDS-PAGE followed by Coomassie staining in Fig. 5B. Also note
that bacterial heat shock protein, DnaK, also co-puriﬁes with GST-
VP2 and its several deletion mutants (Fig. 5B) suggesting that
human heat shock protein 70, Hsp70, may also interact with JCV
VP2 protein as observed for JCV VP3 (Fig. 1B).
Amino acids (aa 281–344) encompassing the DNA binding domain of
VP2/VP3 are sufﬁcient to enhance the LT-Ag binding to Ori
Next, we identiﬁed the region of VP2/VP3 responsible for the
enhancement of LT-Ag binding to Ori. Full length (FL) VP2 and two
deletionmutants, one interacts with LT-Ag (aa 281–344) and the other
does not (aa 1–280) were expressed as GST fusion proteins in bacteria,
afﬁnity puriﬁed, dialyzed against DNA binding buffer as described in
Materials and methods and used in a band shift assay. A recombinant
JCV LT-Ag alone was incubated with a double-stranded probe (Fig. 6B,
lane 2). A labeled DNA probe plus recombinant LT-Ag was also
incubated in combination with puriﬁed GST protein alone (lane 3)
or with GST-VP2 (lane 4, 1–344 FL) or VP2 deletion mutants fused to
GST (lanes 6 and 8) as indicated. DNA–protein complexes were then
separated on a 6% native non-denaturing gel and analyzed by
autoradiography. As shown in Fig. 6B, consistent with the observations
from Fig. 4B, LT-Ag binds to Ori (lane 2) and this binding was
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signiﬁcantly stimulated by VP2 (lane 4 and Fig. 6C). However, the
addition of GST alone or that of an N-terminal deletion mutant of VP2
(aa 1–280) to the binding mixture did not show any appreciable effect
on the enhancement of LT-Ag binding to Ori DNA (Fig. 6B, lane 6
and C). In contrast, a deletion mutant that retained the DNA binding
domain of VP2/VP3 amino acids (aa 281–344) signiﬁcantly stimulated
the binding activity of LT-Ag to the Ori, even more strongly than full
length VP2 (Fig. 6B, lane 8, and C). These ﬁndings demonstrate that
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Fig. 6. The putative DNA binding domain of VP2/VP3 is important for induced DNA
binding activity of LT-Ag to Ori DNA. Labeled probe (A) was incubated either with
LT-Ag alone (50 ng, lane 2) or LT-Ag in combination with GST (1.5 mg, lane 3) or LT-
Ag in combination with GST-VP2 full length (1.5 mg lane 4) or LT-Ag plus VP2
deletion mutants fused to GST (1.5 mg each, lanes 6 and 8) as indicated. DNA-
protein complexes were separated on a 6% PAGE and analyzed by autoradiography
as described in the legend for ﬁg. 4B (B). In lane 1, probe alone was loaded.
(C) Quantitative analysis of the “DNA-protein complexes” on panel B by a semi-
quantitative densitometry method using ImageJ (NIH) and bar graph presentation
of the results in arbitrary units in fold. Protein concentrations for GST and GST-VP2
and GST-VP2 mutants are the same as described for panel B. The DNA binding
efﬁciency of LT-Ag in the presence of VP2 or its mutants was expressed relative to
that of LT-Ag binding to Ori alone.
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Fig. 5. Localization of the domain(s) of VP2 that interacts with LT-Ag. (A) GST-VP2,
and N-terminal and C-terminal VP2 deletion mutants immobilized on GSH-
Sepharose 4B beads were incubated with whole-cell extract prepared from
HJC-15b cells (Raj et al., 1995) for 2 h at 4 1C as described in Material and methods.
The Sepharose beads were washed extensively and proteins interacting with GST or
GST-VP2 or GST-VP2 mutants were separated on a SDS-10% PAGE and analyzed by
western blotting with an anti-LT-Ag antibody (Ab-2, monoclonal). (B) SDS-PAGE
analysis of GST, GST-VP2 and, GST-VP2 N-terminal and C-terminal deletion
mutants. (C) Summary of the results obtained from in vitro mapping assays (from
Fig. 3C and Fig. 5A). The abilities of VP2 and its deletion mutants to interact with LT-
Ag are shown on the right (þ , speciﬁc interaction; -, no interaction, þþ , enhanced
interaction). The positions of molecular weight markers (in kilodaltons, kD) are
shown to the left of panel B.
Fig. 4. JCV VP2 and VP3 enhance LT-Ag binding to Ori DNA sequences. (A) Double-stranded nucleotide structure of the putative JCV core origin of replication. Arrows indicate the
positions of JCV LT-Ag recognition sites. The positions of binding sites I (BS I) and II (BS II) are also indicated. The inverted repeat region (IR) is underlined and the AþT-rich tract (AT) is
identiﬁed by an open bar. Position of the probe used in the band shift assays is marked by a thin line which encompasses the nucleotides of 5064–5115 (JCVMad-1, NC_001699). (B and
C) Band shift assays. The double-stranded nucleotide encompassing nt 5064–5115 Mad-1 was end-labeled with γ-[32P]-dATP (40,000 cpm/lane) and was incubated with different
amount and combinations of the baculovirus-produced JCV LT-Ag, and bacterially produced GST or GST-VP2 or GST-VP3 as indicated on the respective ﬁgures. DNA-protein complexes
were then separated on a 6% native polyacrylamide gel (PAGE) and visualized by autoradiography. In lane 1, probe alone was loaded on the gel. (D) Incubation of LT-Ag with a
nonspeciﬁc DNA probe. In parallel to Fig. 4B, a γ-[32P]-ATP-labeled double stranded nonspeciﬁc DNA probe (see the sequence for it on panel A) was incubated with baculovirus-
produced JCV LT-Ag (50 ng/lane) and formed DNA-protein complexes, if any, were then separated on a 6% native polyacrylamide gel (PAGE) and visualized by autoradiography.
(E) Competitive band shift and antibody super-shift assay. Labeled probewas incubated with ﬁxed amount of LT-Ag (100 ng/lane) as indicated plus with different amounts of unlabeled
oligonucleotide (Comp.¼ Competitor) (1 ng and 5 ng, lanes 3 and 4 respectively). In addition, the reaction mixture was also incubated with either normal mouse serum (NMS) (2 mg)
or α-LT-Ag (2 mg, Ab-2) antibody as indicated. In lane 1, probe alone was loaded on the gel. DNA-protein-antibody complexes were separated on a 6% PAGE under non-denaturing
conditions and analyzed by autoradiography. (F and G) Quantitative analysis of the “DNA-protein complexes” on panels B and C by a semi-quantitative densitometry method using
ImageJ program (NIH) and bar graph presentation of the results in arbitrary units in fold. The DNA binding efﬁciency of LT-Ag in the presence of VP2 or VP3 was expressed relative to
that of LT-Ag binding to Ori alone.
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the DNA binding domain of VP2/VP3 is sufﬁcient for the enhancement
of the LT-Ag binding to Ori, which is consistent with our ﬁndings from
the mapping studies (Fig. 5A, lane 6).
Effect of VP2 on LT-Ag-mediated JCV DNA replication
The observed positive effect of VP2 on DNA binding activity of
LT-Ag to Ori suggested that VP2 may also exert a regulatory effect on
LT-Ag-mediated viral DNA replication. To investigate this possibility,
we performed DpnI replication assays (Sami Saribas et al., 2013).
A replication-competent plasmid containing the JCV origin of DNA
replicationwas introduced alone or in combinationwith a VP2 and LT-
Ag expression plasmids into U-87MG cells. At 72 h posttransfection
the lowmolecular weight DNAwas isolated and digested with BamHI/
DpnI restriction enzymes. BamHI linearizes the input (transfected) and
replicated DNA; and DpnI is known to speciﬁcally digest out the
transfected DNA (bacterially produced and methylated input DNA)
while keeping the newly replicated viral DNA intact (Hirt, 1967). DNA
samples were then analyzed by Southern blotting as described in
Materials and methods. As shown in Fig. 7A, as expected, in the
presence of LT-Ag, a plasmid containing JCV regulatory region of
replication (a replication competent plasmid, pBLCAT3-Mad-1L) was
replicated at detectable level (lane 3). However, in the presence of
increasing amount of a VP2 expression plasmid, a substantial increase
in LT-Ag-mediated viral DNA replication was observed in a dose-
dependent manner (lanes 4 and 5, 2.5 and 6-fold respectively).
VP2 alone showed no ability to induce viral DNA replication (lane 6).
Taken together, these results demonstrate that VP2 can positively
affect LT-Ag-mediated viral DNA replication and functionally plays a
role in JCV life cycle even though it was previously described as a
structural protein (Frisque et al., 1984) and participates in JCV virion
biogenesis. Fig. 7B demonstrates the analysis of the detectable level of
expression of the 3XFLAG-tagged VP2 (full-length, aa 1–344) by
western blotting. Fig. 7C shows equal level of LT-Ag expression in
transfectants from the replication assay (Fig. 7A) conﬁrming that the
induced level of replication of JCV genome observed in transfectants in
Fig. 7A (lanes 4 and 5) is due to the positive effect of VP2 expression on
LT-Ag mediated replication.
Amino acids spaning 281–344 region of VP2 conﬁrms the cooperation
between LT-Ag and VP2 in LT-Ag mediated viral DNA replication
To further assess the functional interaction between VP2/VP3 and
LT-Ag, we examined the effect of deletion mutant VP2 proteins which
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Fig. 7. Effect of VP2 on LT-Ag-mediated JCV DNA replication. (A) DpnI assay. Replication assays were carried out as previously described (Safak et al., 2001). Brieﬂy, a
replication-competent plasmid, pBLCAT3-Mad-1L (late), was transfected alone or in combination with expression vectors into U-87MG (0.4106 cells/60 mm tissue culture
dish) cells as described in materials and methods. At 72 h posttransfection, the low-molecular-weight DNA containing both input and replicated viral DNAwas isolated using
QIAprep spin columns (QIAGEN) (Ziegler et al., 2004), digested with BamHI and DpnI enzymes, resolved on a 1% agarose gel and analyzed by Southern blotting as described
in Materials and methods. The amounts of plasmids used in transfections are indicated on the ﬁgure. The newly replicated DNA is indicated by a labeled arrow (Repl.
DNA¼Replicated DNA). The replication efﬁciency of the pBLCAT3-Mad-1L plasmid was quantitated by a semi-quantitative densitometry method using ImageJ (NIH) and
presented in arbitrary units in fold at the bottom side of the ﬁgure. The replication efﬁciency of pBLCAT3-Mad-1L in the presence of LT-Ag was compared with the other data
points. (B) Transient expression analysis of 3XFLAG-CMV 7.1-VP2 plasmid in U-87MG cells by western blotting using an anti-FLAG antibody as described in materials and
methods. The position of the 3XFLAG-tagged VP2 protein is indicated by a labeled arrow. Transf.: Transfection. (C) Analysis of JCV LT-Ag expression in nuclear extracts
prepared from replication assays in panel A. In parallel to preparing samples for DNA replication assays, nuclear extracts prepared from the transfectants were analyzed for
expression levels of JCV LT-Ag and β-actin for as a gel loading control.
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have retained or lost their binding activity with LT-Ag on JCV
replication in glial cells (U-87MG). We chose a mutant protein [VP2
(aa 1–280)] with no binding activity to LT-Ag and a mutant protein
[VP2 (aa 281–344)] with a strong binding activity to LT-Ag in GST
pull-down assay (Fig. 5A). The mutant VP2 (aa 1–280) that does not
contain the DNA binding domain of the protein, showed no appreci-
able stimulatory effect on the LT-Ag-mediated viral DNA replication
(Fig. 8A, lanes 4 and 5). However, a mutant VP2 (aa 281–344) that
retains the DNA binding domain and exhibits a strong interaction
activity towards LT-Ag signiﬁcantly induced the LT-Ag-mediated viral
DNA replication in a dose-dependent manner (Fig. 8D, lanes 4 and 5),
consistent with our results obtained from full length VP2 replication
studies (Fig. 7A). Collectively, the data from these replication studies
utilizing deletion mutants of VP2, one which physically and function-
ally interact with LT-Ag [VP2 (aa 281–344)] and one which lacks such
activities [VP2 (aa 1–280)], further conﬁrm the signiﬁcance of an
interaction between VP2/VP3 and LT-Ag in regulation of JCV replica-
tion. Of note, the stable expression of VP2 mutants used in replication
assays was investigated by western blotting (Fig. 8B and E) and
therefore the absence of functional interaction between LT-Ag and
VP2 (1–280) mutant may not be attributed to its lack of expression in
transfected cells. In addition, in Fig. 8C and F, the relatively unaltered
expression level of LT-Ag in replication assays (Fig. 8A and D
respectively) was demonstrated by western blotting.
Discussion
JCV replicates and assembles into infectious virions in the
nucleus. However, the molecular mechanism of this process is
not fully understood. In this report, we attempted to shed more
light on this process by analyzing the interactions between viral
minor capsid proteins, VP2/VP3, LT-Ag and a host chaperone
system protein, Hsp70. We demonstrated that Hsp70 interacts
with LT-Ag (Fig. 2B) and viral structural protein, VP3 (Fig. 1B) and
heavily accumulates in the nucleus of the infected cells (Fig. 1D).
It is known that Hsp70 interacts with the J domain (co-chaperone
domain) of LT-Ag (Sullivan et al., 2000, 2001; Sullivan and Pipas,
2002). Note that all early regulatory proteins of JCV contain this J
domain (Fig. 2A), indicating that they all contribute to the JCV
replication cycle. We also demonstrated that viral structural
proteins, VP2/VP3 enhance the DNA binding activity of LT-Ag to
Ori through their C-terminal DNA binding domains (Fig. 6B).
It appears that this enhancement leads to an increase in the level
of LT-Ag mediated viral DNA replication (Figs. 7A and 8D).
Collectively, these results suggest a novel hypothesis in which
Hsp70 mediates an interaction between LT-Ag and the viral capsid
proteins and plays a role in coupling of viral DNA replication to the
virion encapsidation process as illustrated in a model presented in
Fig. 9. According to this model, upon translation, Hsp70 interacts
with the viral capsid proteins, VP2 and VP3, in cytoplasm brings
them to the replication centers in the nucleus and anchors them to
the N-terminus J-domain of LT-Ag, thereby they may also mediate
an interaction between capsid proteins and LT-Ag. This interaction
then induces a conformational change on LT-Ag structure, result-
ing in an enhancement in its DNA binding activity and therefore its
ability to replicate DNA. The newly replicated viral genome is then
captured by VP2/VP3 through their DNA binding domains, initiat-
ing a nucleation process during the initial stages of virion
maturation. This then leads to the coupling of the viral DNA
replication to the virion encapsidation events. Finally, VP1 is added
to the last layer of a virion and the maturation process is
completed and virions are released.
The DNA binding domain of VP2/VP3 was previously character-
ized for JCV (Huang et al., 2003) and SV40 (Clever et al., 1993).
Amino acid comparison studies (Fig. 3B) revealed that the
C-terminal region of VP2/VP3, encompassing the DNA binding
domain of each protein, exhibits high homology between JCV and
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Fig. 8. Effect of VP2 mutants on LT-Ag-mediated JCV DNA replication. (A and D) DpnI assay. Replication assays were carried out as described for Fig. 7A. The amounts of plasmids used
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BKV than that of between JCV and SV40. This comparison also
revealed that the C-terminal regions VP2/VP3 of SV40 and BKV
contain an extra and highly conserved 8 amino acid sequence
(VSRGSSQK for BKV and LSRGSSQK for SV40) than that of JCV. It is
known that JCV is a relatively slow growing virus than BKV and
SV40; and thus the presence or absence of these additional amino
acid sequences may play a consequential role on the efﬁciency of
the encapsidation process of each virus, which ultimately affects,
in part, the propagation rate of these viruses.
Our DNA binding studies demonstrated that capsid proteins,
VP2/VP3, signiﬁcantly stimulate the DNA binding activity of LT-Ag
to Ori without directly interacting with DNA (Fig. 4B and C), which
is similar to a case where we have recently reported an induced
binding activity of LT-Ag in the presence of JC agnoprotein (Saribas
et al., 2012). This is also a novel ﬁnding suggesting that JCV capsid
proteins may be involved in viral DNA replication through inter-
action with LT-Ag. However, these proteins do not seem to form an
apparent ternary complex with LT-Ag/DNA complex under our
band shift assay conditions, which is apparent from the lack of the
alteration in the migration pattern of DNA–protein complexes
upon addition of capsid proteins into the binding mixture (Fig. 4B
and C). These ﬁndings suggest the following possibilities: (i) one
possibility is that interaction of capsid proteins with LT-Ag takes
place off the DNA but induces a conformational change on LT-Ag
protein, resulting in a more efﬁcient DNA binding. The capsid
proteins were then most likely liberated from LT-Ag/capsid protein
complexes before or after LT-Ag binds to DNA (Fig. 4B and C). This
is, at least, one of the reasons that capsid proteins are not the part
of LT-Ag/DNA complex. (ii) Another possibility is that the interac-
tion between capsid proteins and LT-Ag/DNA complex is weak and
therefore is unstable under our gel shift conditions. Nonetheless,
the ability of one protein to inﬂuence the DNA binding capacity of
another one has been well-established. There are previously
reported similar interactions in the literature, including the
stimulation of the serum response factor binding to DNA by Phox1
(Grueneberg et al., 1992), induction of YB-1 binding to the
23-bp element of JCV archetype by LT-Ag (Safak et al., 1999), the
induction of Tst-1 binding to DNA by HMG-1/Y (Leger et al., 1995)
and enhancement of LT-Ag binding to Ori by JCV agnoprotein
(Saribas et al., 2012). We also noticed that although JCV minor
capsid proteins contain a DNA binding domain, we did not detect a
noticeable DNA binding activity by both capsid proteins in our
DNA binding assays, suggesting that either our DNA binding assay
conditions are not favorable for such a binding or the DNA
fragment that was used as a probe in our band shift assays does
not contain a DNA signal sequence for binding of the minor capsid
proteins.
Mapping studies demonstrated that JCV minor capsid proteins,
VP2/VP3 interact with LT-Ag through their DNA binding domains
(aa 281–344) (Fig. 5A) and this region is also sufﬁcient to induce
LT-Ag binding Ori (Fig. 6B). This region also was shown to
stimulate the LT-Ag-mediated viral DNA replication (Fig. 8D). All
these ﬁndings suggest that the DNA binding domain of the capsid
proteins also plays functional roles either in JCV DNA replication or
in virion encapsidation or in both processes. It should be noted
here that we, ﬁrst time, report a functional role for these two
structural proteins of JCV, VP2 and VP3, in viral life cycle. Further
investigations are required to elucidate the details of the func-
tional roles of these proteins in JCV biology.
Viruses are intracellular parasites and recruit host cellular
components for their own replication, protein synthesis and virion
assembly. During the course of virion production, a large number
viral proteins are synthesized in relatively short period of time,
some of which require proper protein folding in order to be
functional and host chaperones are required for this process. In
addition, in order to create a favorable environment for their
propagation, and avoid premature host cell death, viruses need to
interfere with cellular processes including premature induction of
apoptosis, signal transduction and cell cycle regulation pathways.
Many host chaperones including Hsp70s are involved in control of
these cellular processes and some viruses reprogram their host
environment by interfering with the chaperone activity of the host
proteins. Hsp70 chaperones are the central component of the
cellular chaperone network and are being frequently recruited by
Fig. 9. A Model representing the proposed replication-encapsidation coupling for JCV. Hsp70 ﬁrst associates with the capsid proteins (VP2/VP3) and tethers them to LT-Ag
either in the cytoplasm (I) or in the nucleus (II) at the replication centers. This also allows interaction of VP2/VP3 with LT-Ag (i). Interaction of VP2/VP3 with LT-Ag then
induces a conformational change in LT-Ag (ii) resulting in a marked increase in the binding activity of LT-Ag to the Ori (iii). Newly replicated viral DNA is immediately
captured by VP2/VP3 capsid proteins, initiating the coupling of the viral DNA replication to encapsidation (iv and v). Finally, nucleocapsids mature as VP1 wraps around them
(vi) and virions are released. In addition to aforementioned interaction model between Hsp70, (VP2/VP3) and LT-Ag, other possible orders of interactions are also equally
likely. For example, Hsp70/LT-Ag interaction may occur ﬁrst either in the cytoplasm or in the nucleus, and then VP2/VP3 is added to the complex; or (VP2/VP3)/LT-Ag
complex can form ﬁrst, and then Hsp70 is added to the complex either in the cytoplasm or in the nucleus.
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numerous DNA and RNA viruses (Mayer, 2005). Without their
involvement, viruses cannot complete their replication cycle
(Mayer, 2005). Hsp70s are potentially involved in all phases of
the viral life cycle including, cell entry (Guerrero et al., 2002), viral
transcription (Devireddy et al., 2000), virions disassembly, transfer
of viral genome into the nucleus, replication of the viral genome
(Chromy et al., 2003), morphogenesis of the virion particles
(Mayer, 2005; Napuli et al., 2003).
Heat shock families of proteins are critically important for the
replication cycle of many prokaryotic and eukaryotic viruses
(Mayer, 2005). In fact, two of the chaperone systems in Escherichia
coli Hsp70 (DnaK, DnaJ and GrpE) and Hsp60 (GroEL and GroES)
were originally discovered as the host factors essential for
growth of prokaryotic (bacterial) viruses, bacteriophage λ and T4
(Georgopoulos, 1977; Georgopoulos et al., 1972), where it was
demonstrated that the E. coli bacteriophage λ protein λP sequesters
the E. coli DNA helicase DnaB and recruits it to the origin of the
replication of λ bacteriophage and where it interacts with the four
dimers of λO assembled at Ori λ to form a multimeric complex
(Liberek et al., 1988). In the case of eukaryotic viral infections, it was
shown that DNA binding activity of the human papillomavirus-11
(HPV-11) DNA helicase E1 to DNA was stimulated by Hsp70, HdJ1
and HdJ2 in a ATP-dependent manner (Liu et al., 1998). Hsp70
system also was shown to be necessary for the replication of the
SV40 genome. The N-terminus of SV40 LT-Ag, like JC virus and BK
virus LT-Ag, contains a signature motif for J-domain, which is
important for recruiting Hsp70 to the replication centers and
modulating the activity of LT-Ag. There are also reports describing
the involvement of Hsp70 system in virion morphogenesis where
the interaction of Hsp70 with capsid proteins, VP1, VP2 and VP3 of
PyV was demonstrated (Chromy et al., 2003). Puriﬁed VP1 and VP3
was shown to assemble into virion-like structures in the presence of
prokaryotic Hsp70 (DnaK, DnaJ and GrpE) chaperones in an ATP-
dependent manner. Such an assembly was also demonstrated using
a mammalian Hsp70 when the J-domain of SV40 LT-Ag was used as
a co-chaperone (Chromy et al., 2003).
Understanding the molecular mechanisms of the JCV virion
maturation remains elusive. The host heat shock proteins, includ-
ing Hsp70, appear to play important regulatory roles in the JCV
virion maturation process, which is consistent with our ﬁndings
from protein–protein interaction studies data and published
reports (Mayer, 2005). We will further characterize the molecular
mechanisms of the involvement of Hsp70 in JCV virion maturation
particularly in coupling of JCV replication to virion encapsidation
process, which will eventually help us develop effective therapeu-
tic strategies against JCV infections in affected individuals.
Materials and methods
Cell lines
U-87 MG is a cell line that was derived from human malignant
gliomas (ATCC HTB-14) (Ponten and Macintyre, 1968). SVG-A is a
human cell line established by transformation of primary human
fetal glial cells with an origin-defective SV40 mutant (Major et al.,
1985). These transformed cells (SVG-A) do not express either SV40
viral capsid proteins (VPs) or agnoprotein, but express SV40 large T
antigen (LT-Ag). HJC-15b is a hamster glial cell line constitutively
expressing JCV LT-Ag (Raj et al., 1995). These cell lines were grown
in Dulbecco's Modiﬁed Eagle's Medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS) and antibiotics
[penicillin/streptomycin (100 mg/ml), ciproﬂoxacin (10 mg/ml]. They
were maintained at 37 1C in a humidiﬁed atmosphere supplemented
with 7% CO2.
Plasmid constructs
The cloning of JCV LT-Ag into a bacterial expression vector,
pGEX1λT, was previously described (Safak et al., 2001). HPD to
AAA mutations were made on pGEX1λT-LT-Ag by site-directed
mutagenesis using a QuikChange site-directed mutagenesis kit
(Cat#: 210516, Agilent Technologies) and the plasmid was desig-
nated as pGEX1λ-LT-Ag (HPD to AAA). The full-length of JCV VP2
(1–344) and VP3 [VP2 (120–344)]; and the deletion mutants of
each protein were cloned into a bacterial expression vector,
pGEX1λT (GE Health Care, Cat#: 27-4805-01), at BamHI/EcoRI sites
by PCR-based cloning using appropriate PCR primers. The resulting
plasmids were designated as pGEX1λT-VP2 (1–344), pGEX1λT-VP3
(1–244), pGEX1λT-VP2 (1–280), pGEX1λT-VP2 (1–119), pGEX-
1λT-VP2 (120–280), pGEX1λT-VP2 (120–344), pGEX1λT-VP2
(281–344). The full length of JCV VP2 (aa 1–344) and VP3 (aa
1–244) and deletion mutants of VP2 (aa 1–280 and aa 281–344)
were cloned into a eukaryotic expression vector (p3XFLAG-
CMVTM-7.1, Sigma, Cat#: E7533) at BamHI and EcoRI sites. Each
clone was tagged at the N-terminus with a 3X-FLAG peptide
(MDYKDHDGDYKDHDIDYKDDDDK) and designated as p3XFLAG-
CMVTM-7.1-JCV VP2 (1–344), p3XFLAG-CMVTM-7.1-JCV VP3 (1–
244), p3XFLAG-CMVTM-7.1-JCV VP2 (1–280) and p3XFLAG-
CMVTM-7.1-VP2 (281–344). JCV LT-Ag was also cloned into a
eukaryotic expression vector [pcDNA3.1(þ), Invitrogen, Cat#:
V790-20] at EcoRI site and designated as pcDNA3.1(þ)–JCV LT-
Ag, which expresses both LT-Ag and Sm t-Ag. The integrity of all
plasmids was veriﬁed by DNA sequencing.
Expression and puriﬁcation of recombinant proteins
Bacterial expression of Glutathione-S-Transferase (GST) alone
and GST-fusion proteins were previously described (Safak et al.,
2001). Brieﬂy, a 100 ml overnight culture of E. coli DH5α cells
transformed with plasmids expressing either GST alone or full
length VP2/VP3 fused to GST [(GST-VP2 (1–344) and GST-VP3
(1–244)] or different deletion mutants of VP2/VP3 fused to GST
[GST-VP2 (1–280), GST-VP2 (1–119), GST-VP2 (120–280), GST-VP2
(120–344), GST-VP2 (281–344)] were ﬁrst diluted 1:10 in fresh
Luria-Bertani (LB) broth in 1 L supplemented with ampicillin
(100 mg/ml) and grown at 37 1C until at an optical density (at
595 nm) of 0.5. Bacterial cultures were then induced with 0.3 mM
isopropyl-β-thiogalactopyranoside (IPTG) and incubated for an
additional 2 h at 28 1C. Bacterial cells were harvested by centrifu-
gation at 4 1C and pellets were resuspended in 20–40 ml of PENT
lysis buffer containing 20 mM Tris–HCl (pH 8.0), 100 mM NaCl,
1 mM EDTA, 0.5% Nonidet P-40 (NP-40) supplemented with a
cocktail of protease inhibitors (Sigma, Cat #: P8465). Bacterial cells
were ﬁrst sonicated and clear cell lysates were prepared by
centrifugation at 20,000 g. Lysates were then incubated with
200 ml of 50% Glutathione (GSH)-Sepharose 4B beads (GE Health
Care, Cat#: 17-0756-05) in phosphate buffered saline (1 PBS)
overnight at 4 1C. GST fusion proteins bound to beads were
puriﬁed by three cycles of washing and centrifugation with 5 ml
of PENT lysis buffer, eluted with GSH elution buffer (50 mM Tris–
HCl, 10 mM reduced GSH, pH 8.0), dialyzed overnight in band shift
assay sample buffer [12 mM HEPES (pH 7.9), 4 mM Tris–HCl (pH
7.5), 60 mM KCl, 5 mM MgCl2 and 1.0 mM DTT].
JCV LT-Ag was expressed in Spodeptera frugiperda (Sf9) insect
cells using a baculovirus expression system and afﬁnity puriﬁed as
previously described (Bollag et al., 1996). Finally, the protein
quality of each protein after puriﬁcation was determined by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by
Coomassie blue staining.
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Electrophoretic mobility shift assays (EMSA)
EMSA were carried out as previously described (Kim et al.,
2003; Sadowska et al., 2003; Saribas et al., 2012). Brieﬂy, a double-
stranded synthetic oligonucleotide corresponding to the part of
JCV Mad-1 origin (nt 5064–5115) was end-labeled with [γ-32P] ATP
using T4 polynucleotide kinase and gel puriﬁed. Baculovirus-
produced and puriﬁed JCV LT-Ag or bacterially produced and
afﬁnity puriﬁed GST alone or GST-VP2/VP3(full length or their
mutants) were incubated with labeled probe (40,000-cpm/lane)
in different combinations, as described in the respective ﬁgure
legends in 50 ml reaction volume, in binding buffer containing
1.0 μg poly(dI-dC), 12 mM HEPES (N-2-hydroxyethylpipezine-N-2-
ethanesulfonic acid) (pH 7.9), 4 mM Tris–HCl (pH 7.5), 60 mM KCl,
5 mM MgCl2 and 1.0 mM DTT. The reaction mixtures were incu-
bated at 4 1C for 45 min to allow the formation of DNA–protein
complexes. The complexes were then fractionated on a 6% poly-
acrylamide gel in 0.5 TBE [1  TBE is 89 mM Tris–HCl (pH 8.0),
89 mM boric acid, and 2 mM EDTA (pH 8.0)]. The gel was dried and
DNA–protein complexes were detected by autoradiography.
Detailed experimental conditions for all band shift assays are
described in the respective ﬁgure legends.
GST afﬁnity chromatography (GST pulldown) and
coimmunoprecipitation assays
GST pull-down assay was performed as previously described
(Safak et al., 2001). Brieﬂy, 2 mg of either GST alone, or GST-VP2 wt
(full length) or JCV VP2 deletion mutants fused to GST, immobi-
lized on GSH-Sepharose 4B beads were incubated with 0.3 mg of
whole-cell extract prepared from hamster glial cells (HJC-15b)
constitutively expressing JCV LT-Ag (Raj et al., 1995), for 2 h at 4 1C
in lysis buffer containing 50 mM Tris–HCl (pH 7.4), 150 mM NaCl,
and 0.5% NP-40. The protein–complexed beads were washed
extensively with lysis buffer and resolved by SDS-10% PAGE
followed by western blot analysis using anti-LT-Ag antibody [Ab-2,
mouse mAb (PAb416), EMD Millipore, Cat#: DP02-200UG]. Amer-
sham ECL prime western blot detection system (Cat#: RPN2232) was
used to develop western blots. Ab-2 monoclonal antibody was raised
against SV40 LT-Ag but cross-reacts with JCV LT-Ag. Similarly, GST
pull-down assays were also performed to examine an interaction
between GST-JCV LT-Ag (2 mg fusion protein) and human heat shock
protein Hsp70 (0.3 mg of whole cell extract prepared from U-87 MG)
and that between GST-JCV VP3 (2 mg fusion protein) and Hsp70
(0.3 mg of whole cell extract prepared from U-87 MG) as described
above using anti-Hsp70 antibody (W2) ( Santa Cruz, Cat#: SC-24). In
vivo interaction of Hsp70 with LT-Ag and that of capsid protein, VP2,
with both LT-Ag and Hsp70 were examined by coimmunoprecipita-
tion assays as described under respective ﬁgure legends.
Indirect immunoﬂuorescence microscopy
Indirect immunoﬂuorescence microscopy studies were per-
formed as previously described (Sadowska et al., 2003; Sariyer
et al., 2011). Brieﬂy, SVG-A cells were transfected/infected with
pBluescript KS (þ)–JCV Mad-1 WT DNA already linearized by
BamHI restriction enzyme digestion and at 5th day posttransfec-
tion/infection, cells were seeded at subconﬂuency on polylysine-
coated glass chamber slides (Thermo Scientiﬁc, Cat#:177380).
The next day, cells were washed twice with 1PBS and ﬁxed in
ice-cold acetone. Fixed cells were then blocked with 5% bovine
serum albumin in 1 PBS for 2 h, and incubated with two
different antibody combinations (anti-JCV Agno primary polyclo-
nal rabbit antibody (1–200 dilution), Del Valle et al., 2002) plus
anti-Hsp70 monoclonal mouse antibody (Santa Cruz, Cat#: SC-24,
1:100 dilution) overnight. Antibody dilution and incubation were
performed in incubation buffer (PBST¼[1 PBS-0.01% Tween 20]
buffer. Cells were then washed three times with PBST buffer for
10 min intervals and subsequently incubated with a Rhodamine-
conjugated goat anti-mouse plus ﬂuorescein isothiocyanate (FITC)-
conjugated goat anti-rabbit secondary antibodies (BD Biosciences)
for 45 min. Cell were ﬁnally washed with incubation buffer three
times at 10 min intervals, mounted using Vectashield mounting
media (Vector Laboratories Inc., Cat#: H-1200) and examined
under a ﬂuorescence microscope (Nikon eclipse TE300; objectives:
40 /1.3 oil and eyepiece: 10 ; operating software: Slidebook 5.0.)
for detection of JCV agnoprotein and Hsp70.
Replication assays
Replication assays were carried out as previously described
(Safak et al., 2001). Brieﬂy, a replication-competent plasmid,
pBLCAT3-Mad-1 L, containing the regulatory region of the Mad-1
strain of JCV in late orientation (L), was introduced alone or in
combination with eukaryotic expression vectors, pcDNA3.1(þ) JCV
LT-Ag, p3XFLAG-CMVTM-7.1-JCV VP2, p3XFLAG-CMVTM-7.1-JCV
VP2 (1–280) and p3XFLAG-CMVTM-7.1-VP2 (281–34), into
U-87 MG (0.4106 cells/60 mm tissue culture dish) cells with
the calcium phosphate (CaPO4) precipitation method (Kim et al.,
2003). Plasmid concentrations used in transfections are indicated
in the respective ﬁgure legends, and the total amount of DNA
transfected into the cells was normalized with appropriate empty
DNA vectors. Cells were washed with 1PBS at 3 h posttransfec-
tion and the medium was replenished. At 72 h posttransfection,
the low-molecular-weight DNA containing both input and repli-
cated viral DNA was isolated using QIApreps small spin columns
(QIAGEN) as previously described (Ziegler et al., 2004), digested
with BamHI and DpnI enzymes, resolved on a 1% agarose gel and
analyzed by Southern blotting. DpnI enzyme speciﬁcally digests
transfected and bacterially methylated DNA and leaves the
newly replicated DNA intact. Probes for Southern blots were
prepared using pBLCAT3-Mad-1 L (late) plasmid as a template in
a ready-prime random labeling reaction (Cat#: 300385, Agilent
Technologies Inc).
Preparation of whole-cell and nuclear extracts for western blotting
Whole cell extracts were prepared as described previously (Safak
et al., 2001). Brieﬂy, U-87 MG cells (1106) were lysed in a lysis
buffer containing 50 mM Tris–HCl (pH 7.4), 150 mM NaCl, and 0.5%
NP-40) on a racking platform at 4 1C for 20 min. Cell lysate was then
cleared by centrifugation at 15,000 for 5 min at 4 1C and stored at
70 1C until use. Nuclear extracts were prepared as previously
described (Kim et al., 2003). Brieﬂy, U-87 MG cells (1106 cells/
100 mm culture dish) were separately transfected with a VP2 and its
deletion mutant expression plasmids [p3XFLAG-CMVTM-7.1-JCV VP2,
p3XFLAG-CMVTM-7.1-JCV VP2 (1–280) and p3XFLAG-CMVTM-7.1-
VP2 (281–34)] by CaPO4 method and second day posttranfection,
nuclear extracts were prepared by a modiﬁcation of the miniextract
protocol, as described earlier (Schreiber et al., 1989). Transfected and
untransfected cells were harvested by trypsinization, washed once
with complete DMEM and twice with 1PBS, and transferred to an
Eppendorf tube. The cells were then resuspended in cold hypotonic
buffer [10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM
ethylene glycol bis(β-aminoethyl ether)-N,N,N,N,-tetraacetic acid
(EGTA), 1 mM dithiothreitol (DTT), and protease inhibitors Cat #:
P8340, Sigma] and allowed to swell on ice. Cellular membranes were
cleared by the addition of NP-40 (0.5% ﬁnal concentration) and
vortexing for 12 s in full speed. The nuclei were pelleted by
centrifugation at 6,000 RPM (Eppendorf microcentrifuge), resus-
pended in cold extraction buffer containing 20 mM HEPES (pH 7.9),
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0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, and 1 mM DTT and supple-
mented with a cocktail of protease inhibitors (Sigma, Cat#: P8340),
and extracted at 4 1C for 15 min on a racking platform. The nuclear
extracts were centrifuged at 15,000 RPM (Eppendorf microcentrifuge)
for 5 min and the cleared supernatant was frozen at 70 1C until use.
In parallel to preparing DNA samples for DNA replication assays,
nuclear extracts were also prepared to analyze the expression level of
LT-Ag from transfectants by western blotting as described above.
Western blotting
Expression plasmids [p3XFLAG-CMVTM-7.1-JCV VP2 (1–344),
p3XFLAG-CMVTM-7.1-JCV VP2 (1–280) and p3XFLAG-CMVTM-7.1-
VP2 (281–344)] were transfected into U-87 MG cells by the CaPO4
precipitation method (Kim et al., 2003). At 48 h posttransfection,
nuclear extracts were prepared from transfected and untrans-
fected cells. Forty micrograms of the nuclear extract were analyzed
for full length JCV VP2 by 10% SDS-PAGE followed by western
blotting using anti-FLAG M2 antibody (Cat # 200470-21, Agilent
Technologies Inc.). Expression of the deletion mutants of JCV VP2
(aa 1–280 and aa 281–344) was analyzed on a 4–20% NuPAGEs
Bis-Tris gel (Life TechnologiesTM) and followed by western blotting
as described for JCV VP2 above using monoclonal anti-FLAG M2
antibody. JCV LT-Ag expression was also analyzed in nuclear
extracts prepared from the transfectants used for DNA replication
assays. Blots were probed with a primary anti-SV40 LT-Ag anti-
body (Ab-2, EMD Millipore, Cat #: DP02-200UG), which is also
cross-reactive with JCV LT-Ag, and with secondary goat anti-
mouse antibody (IRDYE 680 LT, LI-COR) and were analyzed using
LI-COR Odyssey CLX instrument. Blots were also probed with a
primary monoclonal anti-β-actin (Sigma, Cat #: A5441) and
secondary goat anti-mouse antibody labeled with IRDYE 800 CW
(LI-COR) and were analyzed on LI-COR Odyssey CLX instrument.
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